BUD vs CHRS
BUD (BUD) versus Coherus BioSciences Inc (CHRS) — a side-by-side from cached financials, not a winner call.
BUD (BUD) common stock.
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
BUD does not have a complete income-statement cache yet.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
BUD currently screens at market cap $0. CHRS currently screens at market cap $223.7M.
Not investment advice. Open the BUD and CHRS stock pages for the full models.
Not investment advice.